Advancements in hepatocellular carcinoma diagnosis and treatment: liquid biopsy and surgery as precision treatment

Alessandro D. Mazzotta , Desirée Bonci

Hepatoma Research ›› 2024, Vol. 10 : 8

PDF
Hepatoma Research ›› 2024, Vol. 10:8 DOI: 10.20517/2394-5079.2024.13
Editorial

Advancements in hepatocellular carcinoma diagnosis and treatment: liquid biopsy and surgery as precision treatment

Author information +
History +
PDF

Cite this article

Download citation ▾
Alessandro D. Mazzotta, Desirée Bonci. Advancements in hepatocellular carcinoma diagnosis and treatment: liquid biopsy and surgery as precision treatment. Hepatoma Research, 2024, 10: 8 DOI:10.20517/2394-5079.2024.13

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Yang JD,Gores GJ,Plymoth A.A global view of hepatocellular carcinoma: trends, risk, prevention and management.Nat Rev Gastroenterol Hepatol2019;16:589-604 PMCID:PMC6813818

[2]

von Felden J,Schulze K,Villanueva A.Liquid biopsy in the clinical management of hepatocellular carcinoma.Gut2020;69:2025-34

[3]

Tey SK,Chan JYT.Patient pIgR-enriched extracellular vesicles drive cancer stemness, tumorigenesis and metastasis in hepatocellular carcinoma.J Hepatol2022;76:883-95

[4]

Sun N,Zhang RY.Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring.Nat Commun2020;11:4489 PMCID:PMC7477161

[5]

Wang Y,Zhang P.Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.Cancer Med2018;7:1670-9 PMCID:PMC5943469

[6]

Kim SS,Ahn HR.Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma.Mol Oncol2020;14:2646-59 PMCID:PMC7530776

[7]

Cai J,Zhang Z.Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma.Gut2019;68:2195-205 PMCID:PMC6872444

[8]

Cai Z,Zeng Y.Comprehensive liquid profiling of circulating tumor DNA and protein biomarkers in long-term follow-up patients with hepatocellular carcinoma.Clin Cancer Res2019;25:5284-94

[9]

Marrero JA,Sirlin CB.Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American association for the study of liver diseases.Hepatology2018;68:723-50

[10]

Lee S,Cha DI.Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.J Hepatol2018;69:70-8

[11]

Heimbach JK,Finn RS.AASLD guidelines for the treatment of hepatocellular carcinoma.Hepatology2018;67:358-80

[12]

Bruix J.American Association for the Study of Liver DiseasesManagement of hepatocellular carcinoma: an update.Hepatology2011;53:1020-2

[13]

Mazzaferro V,Doci R.Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.N Engl J Med1996;334:693-700

[14]

Lin CH,Wu CH.Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis.Surg Endosc2020;34:5566-73

[15]

Mondaca S,Pinto M.Biliary tract cancer prognostic and predictive genomics.Chin Clin Oncol2019;8:42 PMCID:PMC7910699

PDF

41

Accesses

0

Citation

Detail

Sections
Recommended

/